nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—Azatadine—Loratadine—atopic dermatitis	0.166	0.399	CrCrCtD
Nortriptyline—ORM1—Tacrolimus—atopic dermatitis	0.0558	0.127	CbGbCtD
Nortriptyline—CHRM2—Dimenhydrinate—atopic dermatitis	0.0476	0.109	CbGbCtD
Nortriptyline—HRH1—Dimenhydrinate—atopic dermatitis	0.0434	0.0991	CbGbCtD
Nortriptyline—Doxepin—Diphenhydramine—atopic dermatitis	0.0422	0.101	CrCrCtD
Nortriptyline—Cyclobenzaprine—Diphenhydramine—atopic dermatitis	0.0396	0.0951	CrCrCtD
Nortriptyline—Dimetindene—Diphenhydramine—atopic dermatitis	0.0385	0.0924	CrCrCtD
Nortriptyline—Amitriptyline—Diphenhydramine—atopic dermatitis	0.0355	0.0852	CrCrCtD
Nortriptyline—Atomoxetine—Diphenhydramine—atopic dermatitis	0.033	0.0791	CrCrCtD
Nortriptyline—Trimipramine—Diphenhydramine—atopic dermatitis	0.0322	0.0773	CrCrCtD
Nortriptyline—Imipramine—Diphenhydramine—atopic dermatitis	0.0295	0.0709	CrCrCtD
Nortriptyline—ALB—Tacrolimus—atopic dermatitis	0.0235	0.0536	CbGbCtD
Nortriptyline—CHRM2—Diphenhydramine—atopic dermatitis	0.0232	0.053	CbGbCtD
Nortriptyline—PTGS1—Diphenhydramine—atopic dermatitis	0.023	0.0525	CbGbCtD
Nortriptyline—HRH1—Loratadine—atopic dermatitis	0.0212	0.0484	CbGbCtD
Nortriptyline—HRH1—Diphenhydramine—atopic dermatitis	0.0212	0.0484	CbGbCtD
Nortriptyline—CYP3A5—Tacrolimus—atopic dermatitis	0.0189	0.0431	CbGbCtD
Nortriptyline—CYP3A4—Pimecrolimus—atopic dermatitis	0.0124	0.0282	CbGbCtD
Nortriptyline—CYP2C19—Diphenhydramine—atopic dermatitis	0.0111	0.0254	CbGbCtD
Nortriptyline—CYP2C19—Loratadine—atopic dermatitis	0.0111	0.0254	CbGbCtD
Nortriptyline—CYP1A2—Diphenhydramine—atopic dermatitis	0.0103	0.0235	CbGbCtD
Nortriptyline—ALB—Prednisone—atopic dermatitis	0.00952	0.0217	CbGbCtD
Nortriptyline—CYP2C9—Loratadine—atopic dermatitis	0.00926	0.0211	CbGbCtD
Nortriptyline—CYP2C9—Diphenhydramine—atopic dermatitis	0.00926	0.0211	CbGbCtD
Nortriptyline—CYP2D6—Diphenhydramine—atopic dermatitis	0.00847	0.0193	CbGbCtD
Nortriptyline—CYP2D6—Loratadine—atopic dermatitis	0.00847	0.0193	CbGbCtD
Nortriptyline—CYP3A5—Hydrocortisone—atopic dermatitis	0.00768	0.0175	CbGbCtD
Nortriptyline—CYP3A4—Tacrolimus—atopic dermatitis	0.00736	0.0168	CbGbCtD
Nortriptyline—CYP2C19—Prednisone—atopic dermatitis	0.00617	0.0141	CbGbCtD
Nortriptyline—CYP2E1—Dexamethasone—atopic dermatitis	0.00615	0.014	CbGbCtD
Nortriptyline—CYP3A4—Loratadine—atopic dermatitis	0.00539	0.0123	CbGbCtD
Nortriptyline—CYP3A4—Methylprednisolone—atopic dermatitis	0.00493	0.0112	CbGbCtD
Nortriptyline—CYP3A5—Dexamethasone—atopic dermatitis	0.00478	0.0109	CbGbCtD
Nortriptyline—CYP2C19—Dexamethasone—atopic dermatitis	0.00385	0.0088	CbGbCtD
Nortriptyline—CYP3A4—Triamcinolone—atopic dermatitis	0.00373	0.00852	CbGbCtD
Nortriptyline—CYP2C9—Dexamethasone—atopic dermatitis	0.0032	0.00731	CbGbCtD
Nortriptyline—CYP3A4—Betamethasone—atopic dermatitis	0.0032	0.00731	CbGbCtD
Nortriptyline—CYP3A4—Prednisolone—atopic dermatitis	0.00316	0.00721	CbGbCtD
Nortriptyline—CYP3A4—Hydrocortisone—atopic dermatitis	0.003	0.00684	CbGbCtD
Nortriptyline—CYP3A4—Prednisone—atopic dermatitis	0.00298	0.00681	CbGbCtD
Nortriptyline—CYP2D6—Dexamethasone—atopic dermatitis	0.00293	0.00669	CbGbCtD
Nortriptyline—CYP3A4—Dexamethasone—atopic dermatitis	0.00186	0.00425	CbGbCtD
Nortriptyline—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000109	0.000982	CcSEcCtD
Nortriptyline—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000109	0.000979	CcSEcCtD
Nortriptyline—Eye disorder—Methylprednisolone—atopic dermatitis	0.000107	0.000965	CcSEcCtD
Nortriptyline—Erectile dysfunction—Prednisone—atopic dermatitis	0.000105	0.000941	CcSEcCtD
Nortriptyline—Hallucination—Dexamethasone—atopic dermatitis	0.000104	0.000935	CcSEcCtD
Nortriptyline—Hallucination—Betamethasone—atopic dermatitis	0.000104	0.000935	CcSEcCtD
Nortriptyline—Nausea—Mometasone—atopic dermatitis	0.000104	0.000935	CcSEcCtD
Nortriptyline—Weight increased—Prednisone—atopic dermatitis	0.000103	0.00093	CcSEcCtD
Nortriptyline—Arrhythmia—Triamcinolone—atopic dermatitis	0.000103	0.000925	CcSEcCtD
Nortriptyline—Weight decreased—Prednisone—atopic dermatitis	0.000103	0.000925	CcSEcCtD
Nortriptyline—Vision blurred—Prednisolone—atopic dermatitis	0.000103	0.000924	CcSEcCtD
Nortriptyline—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000102	0.000923	CcSEcCtD
Nortriptyline—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000102	0.000923	CcSEcCtD
Nortriptyline—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000101	0.000909	CcSEcCtD
Nortriptyline—Asthenia—Tacrolimus—atopic dermatitis	9.98e-05	0.000898	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Prednisone—atopic dermatitis	9.98e-05	0.000898	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Prednisone—atopic dermatitis	9.92e-05	0.000893	CcSEcCtD
Nortriptyline—Myocardial infarction—Prednisone—atopic dermatitis	9.92e-05	0.000893	CcSEcCtD
Nortriptyline—Ill-defined disorder—Hydrocortisone—atopic dermatitis	9.86e-05	0.000888	CcSEcCtD
Nortriptyline—Pruritus—Tacrolimus—atopic dermatitis	9.84e-05	0.000886	CcSEcCtD
Nortriptyline—Malaise—Prednisolone—atopic dermatitis	9.81e-05	0.000884	CcSEcCtD
Nortriptyline—Dysgeusia—Triamcinolone—atopic dermatitis	9.8e-05	0.000883	CcSEcCtD
Nortriptyline—Syncope—Prednisolone—atopic dermatitis	9.76e-05	0.000879	CcSEcCtD
Nortriptyline—Eye disorder—Betamethasone—atopic dermatitis	9.75e-05	0.000878	CcSEcCtD
Nortriptyline—Eye disorder—Dexamethasone—atopic dermatitis	9.75e-05	0.000878	CcSEcCtD
Nortriptyline—Malaise—Hydrocortisone—atopic dermatitis	9.59e-05	0.000863	CcSEcCtD
Nortriptyline—Loss of consciousness—Prednisolone—atopic dermatitis	9.57e-05	0.000861	CcSEcCtD
Nortriptyline—Syncope—Hydrocortisone—atopic dermatitis	9.53e-05	0.000858	CcSEcCtD
Nortriptyline—Diarrhoea—Tacrolimus—atopic dermatitis	9.52e-05	0.000857	CcSEcCtD
Nortriptyline—Convulsion—Prednisolone—atopic dermatitis	9.43e-05	0.000849	CcSEcCtD
Nortriptyline—Hypertension—Prednisolone—atopic dermatitis	9.4e-05	0.000846	CcSEcCtD
Nortriptyline—Loss of consciousness—Hydrocortisone—atopic dermatitis	9.34e-05	0.000841	CcSEcCtD
Nortriptyline—Arrhythmia—Betamethasone—atopic dermatitis	9.32e-05	0.000839	CcSEcCtD
Nortriptyline—Arrhythmia—Dexamethasone—atopic dermatitis	9.32e-05	0.000839	CcSEcCtD
Nortriptyline—Ill-defined disorder—Triamcinolone—atopic dermatitis	9.29e-05	0.000836	CcSEcCtD
Nortriptyline—Ill-defined disorder—Methylprednisolone—atopic dermatitis	9.27e-05	0.000834	CcSEcCtD
Nortriptyline—Alopecia—Dexamethasone—atopic dermatitis	9.22e-05	0.00083	CcSEcCtD
Nortriptyline—Alopecia—Betamethasone—atopic dermatitis	9.22e-05	0.00083	CcSEcCtD
Nortriptyline—Convulsion—Hydrocortisone—atopic dermatitis	9.21e-05	0.000829	CcSEcCtD
Nortriptyline—Dizziness—Tacrolimus—atopic dermatitis	9.2e-05	0.000828	CcSEcCtD
Nortriptyline—Hypertension—Hydrocortisone—atopic dermatitis	9.18e-05	0.000826	CcSEcCtD
Nortriptyline—Discomfort—Prednisolone—atopic dermatitis	9.15e-05	0.000824	CcSEcCtD
Nortriptyline—Hallucination—Prednisone—atopic dermatitis	9.04e-05	0.000814	CcSEcCtD
Nortriptyline—Malaise—Triamcinolone—atopic dermatitis	9.03e-05	0.000813	CcSEcCtD
Nortriptyline—Anxiety—Hydrocortisone—atopic dermatitis	9.02e-05	0.000812	CcSEcCtD
Nortriptyline—Malaise—Methylprednisolone—atopic dermatitis	9.01e-05	0.000811	CcSEcCtD
Nortriptyline—Syncope—Triamcinolone—atopic dermatitis	8.98e-05	0.000808	CcSEcCtD
Nortriptyline—Syncope—Methylprednisolone—atopic dermatitis	8.96e-05	0.000806	CcSEcCtD
Nortriptyline—Discomfort—Hydrocortisone—atopic dermatitis	8.94e-05	0.000805	CcSEcCtD
Nortriptyline—Oedema—Prednisolone—atopic dermatitis	8.88e-05	0.0008	CcSEcCtD
Nortriptyline—Vomiting—Tacrolimus—atopic dermatitis	8.84e-05	0.000796	CcSEcCtD
Nortriptyline—Loss of consciousness—Triamcinolone—atopic dermatitis	8.8e-05	0.000792	CcSEcCtD
Nortriptyline—Loss of consciousness—Methylprednisolone—atopic dermatitis	8.78e-05	0.00079	CcSEcCtD
Nortriptyline—Rash—Tacrolimus—atopic dermatitis	8.77e-05	0.00079	CcSEcCtD
Nortriptyline—Dermatitis—Tacrolimus—atopic dermatitis	8.76e-05	0.000789	CcSEcCtD
Nortriptyline—Shock—Prednisolone—atopic dermatitis	8.74e-05	0.000787	CcSEcCtD
Nortriptyline—Headache—Tacrolimus—atopic dermatitis	8.71e-05	0.000784	CcSEcCtD
Nortriptyline—Oedema—Hydrocortisone—atopic dermatitis	8.68e-05	0.000781	CcSEcCtD
Nortriptyline—Convulsion—Triamcinolone—atopic dermatitis	8.67e-05	0.000781	CcSEcCtD
Nortriptyline—Tachycardia—Prednisolone—atopic dermatitis	8.67e-05	0.000781	CcSEcCtD
Nortriptyline—Convulsion—Methylprednisolone—atopic dermatitis	8.65e-05	0.000779	CcSEcCtD
Nortriptyline—Hypertension—Triamcinolone—atopic dermatitis	8.64e-05	0.000778	CcSEcCtD
Nortriptyline—Hypertension—Methylprednisolone—atopic dermatitis	8.62e-05	0.000776	CcSEcCtD
Nortriptyline—Hyperhidrosis—Prednisolone—atopic dermatitis	8.59e-05	0.000773	CcSEcCtD
Nortriptyline—Shock—Hydrocortisone—atopic dermatitis	8.53e-05	0.000769	CcSEcCtD
Nortriptyline—Eye disorder—Prednisone—atopic dermatitis	8.49e-05	0.000765	CcSEcCtD
Nortriptyline—Anxiety—Methylprednisolone—atopic dermatitis	8.47e-05	0.000763	CcSEcCtD
Nortriptyline—Tachycardia—Hydrocortisone—atopic dermatitis	8.47e-05	0.000762	CcSEcCtD
Nortriptyline—Flushing—Prednisone—atopic dermatitis	8.43e-05	0.000759	CcSEcCtD
Nortriptyline—Ill-defined disorder—Dexamethasone—atopic dermatitis	8.43e-05	0.000759	CcSEcCtD
Nortriptyline—Ill-defined disorder—Betamethasone—atopic dermatitis	8.43e-05	0.000759	CcSEcCtD
Nortriptyline—Discomfort—Triamcinolone—atopic dermatitis	8.42e-05	0.000758	CcSEcCtD
Nortriptyline—Discomfort—Methylprednisolone—atopic dermatitis	8.4e-05	0.000756	CcSEcCtD
Nortriptyline—Hyperhidrosis—Hydrocortisone—atopic dermatitis	8.39e-05	0.000755	CcSEcCtD
Nortriptyline—Dry mouth—Triamcinolone—atopic dermatitis	8.33e-05	0.00075	CcSEcCtD
Nortriptyline—Anorexia—Hydrocortisone—atopic dermatitis	8.27e-05	0.000745	CcSEcCtD
Nortriptyline—Nausea—Tacrolimus—atopic dermatitis	8.26e-05	0.000744	CcSEcCtD
Nortriptyline—Confusional state—Methylprednisolone—atopic dermatitis	8.22e-05	0.00074	CcSEcCtD
Nortriptyline—Malaise—Betamethasone—atopic dermatitis	8.19e-05	0.000737	CcSEcCtD
Nortriptyline—Malaise—Dexamethasone—atopic dermatitis	8.19e-05	0.000737	CcSEcCtD
Nortriptyline—Oedema—Triamcinolone—atopic dermatitis	8.17e-05	0.000736	CcSEcCtD
Nortriptyline—Syncope—Dexamethasone—atopic dermatitis	8.14e-05	0.000733	CcSEcCtD
Nortriptyline—Syncope—Betamethasone—atopic dermatitis	8.14e-05	0.000733	CcSEcCtD
Nortriptyline—Arrhythmia—Prednisone—atopic dermatitis	8.12e-05	0.000731	CcSEcCtD
Nortriptyline—Hypotension—Hydrocortisone—atopic dermatitis	8.11e-05	0.00073	CcSEcCtD
Nortriptyline—Shock—Triamcinolone—atopic dermatitis	8.04e-05	0.000724	CcSEcCtD
Nortriptyline—Insomnia—Prednisolone—atopic dermatitis	8.03e-05	0.000723	CcSEcCtD
Nortriptyline—Alopecia—Prednisone—atopic dermatitis	8.03e-05	0.000723	CcSEcCtD
Nortriptyline—Shock—Methylprednisolone—atopic dermatitis	8.02e-05	0.000722	CcSEcCtD
Nortriptyline—Loss of consciousness—Dexamethasone—atopic dermatitis	7.98e-05	0.000719	CcSEcCtD
Nortriptyline—Loss of consciousness—Betamethasone—atopic dermatitis	7.98e-05	0.000719	CcSEcCtD
Nortriptyline—Paraesthesia—Prednisolone—atopic dermatitis	7.98e-05	0.000718	CcSEcCtD
Nortriptyline—Tachycardia—Triamcinolone—atopic dermatitis	7.97e-05	0.000718	CcSEcCtD
Nortriptyline—Tachycardia—Methylprednisolone—atopic dermatitis	7.95e-05	0.000716	CcSEcCtD
Nortriptyline—Hyperhidrosis—Triamcinolone—atopic dermatitis	7.9e-05	0.000711	CcSEcCtD
Nortriptyline—Hyperhidrosis—Methylprednisolone—atopic dermatitis	7.88e-05	0.000709	CcSEcCtD
Nortriptyline—Convulsion—Dexamethasone—atopic dermatitis	7.87e-05	0.000709	CcSEcCtD
Nortriptyline—Convulsion—Betamethasone—atopic dermatitis	7.87e-05	0.000709	CcSEcCtD
Nortriptyline—Insomnia—Hydrocortisone—atopic dermatitis	7.85e-05	0.000707	CcSEcCtD
Nortriptyline—Hypertension—Dexamethasone—atopic dermatitis	7.84e-05	0.000706	CcSEcCtD
Nortriptyline—Hypertension—Betamethasone—atopic dermatitis	7.84e-05	0.000706	CcSEcCtD
Nortriptyline—Paraesthesia—Hydrocortisone—atopic dermatitis	7.79e-05	0.000701	CcSEcCtD
Nortriptyline—Anxiety—Dexamethasone—atopic dermatitis	7.7e-05	0.000694	CcSEcCtD
Nortriptyline—Anxiety—Betamethasone—atopic dermatitis	7.7e-05	0.000694	CcSEcCtD
Nortriptyline—Discomfort—Dexamethasone—atopic dermatitis	7.64e-05	0.000688	CcSEcCtD
Nortriptyline—Discomfort—Betamethasone—atopic dermatitis	7.64e-05	0.000688	CcSEcCtD
Nortriptyline—Dyspepsia—Hydrocortisone—atopic dermatitis	7.64e-05	0.000688	CcSEcCtD
Nortriptyline—Hypotension—Methylprednisolone—atopic dermatitis	7.62e-05	0.000686	CcSEcCtD
Nortriptyline—Decreased appetite—Hydrocortisone—atopic dermatitis	7.54e-05	0.000679	CcSEcCtD
Nortriptyline—Fatigue—Hydrocortisone—atopic dermatitis	7.48e-05	0.000673	CcSEcCtD
Nortriptyline—Vision blurred—Prednisone—atopic dermatitis	7.45e-05	0.000671	CcSEcCtD
Nortriptyline—Oedema—Dexamethasone—atopic dermatitis	7.41e-05	0.000667	CcSEcCtD
Nortriptyline—Oedema—Betamethasone—atopic dermatitis	7.41e-05	0.000667	CcSEcCtD
Nortriptyline—Insomnia—Triamcinolone—atopic dermatitis	7.39e-05	0.000665	CcSEcCtD
Nortriptyline—Insomnia—Methylprednisolone—atopic dermatitis	7.37e-05	0.000664	CcSEcCtD
Nortriptyline—Ill-defined disorder—Prednisone—atopic dermatitis	7.34e-05	0.000661	CcSEcCtD
Nortriptyline—Paraesthesia—Triamcinolone—atopic dermatitis	7.33e-05	0.00066	CcSEcCtD
Nortriptyline—Feeling abnormal—Prednisolone—atopic dermatitis	7.32e-05	0.000659	CcSEcCtD
Nortriptyline—Paraesthesia—Methylprednisolone—atopic dermatitis	7.32e-05	0.000659	CcSEcCtD
Nortriptyline—Shock—Dexamethasone—atopic dermatitis	7.29e-05	0.000657	CcSEcCtD
Nortriptyline—Shock—Betamethasone—atopic dermatitis	7.29e-05	0.000657	CcSEcCtD
Nortriptyline—Agitation—Prednisone—atopic dermatitis	7.27e-05	0.000654	CcSEcCtD
Nortriptyline—Thrombocytopenia—Dexamethasone—atopic dermatitis	7.26e-05	0.000653	CcSEcCtD
Nortriptyline—Thrombocytopenia—Betamethasone—atopic dermatitis	7.26e-05	0.000653	CcSEcCtD
Nortriptyline—Tachycardia—Dexamethasone—atopic dermatitis	7.23e-05	0.000651	CcSEcCtD
Nortriptyline—Tachycardia—Betamethasone—atopic dermatitis	7.23e-05	0.000651	CcSEcCtD
Nortriptyline—Dyspepsia—Triamcinolone—atopic dermatitis	7.19e-05	0.000647	CcSEcCtD
Nortriptyline—Dyspepsia—Methylprednisolone—atopic dermatitis	7.17e-05	0.000646	CcSEcCtD
Nortriptyline—Hyperhidrosis—Betamethasone—atopic dermatitis	7.17e-05	0.000645	CcSEcCtD
Nortriptyline—Hyperhidrosis—Dexamethasone—atopic dermatitis	7.17e-05	0.000645	CcSEcCtD
Nortriptyline—Feeling abnormal—Hydrocortisone—atopic dermatitis	7.15e-05	0.000644	CcSEcCtD
Nortriptyline—Malaise—Prednisone—atopic dermatitis	7.13e-05	0.000642	CcSEcCtD
Nortriptyline—Syncope—Prednisone—atopic dermatitis	7.09e-05	0.000639	CcSEcCtD
Nortriptyline—Anorexia—Betamethasone—atopic dermatitis	7.07e-05	0.000636	CcSEcCtD
Nortriptyline—Anorexia—Dexamethasone—atopic dermatitis	7.07e-05	0.000636	CcSEcCtD
Nortriptyline—Urticaria—Prednisolone—atopic dermatitis	7.06e-05	0.000635	CcSEcCtD
Nortriptyline—Fatigue—Triamcinolone—atopic dermatitis	7.04e-05	0.000634	CcSEcCtD
Nortriptyline—Fatigue—Methylprednisolone—atopic dermatitis	7.03e-05	0.000633	CcSEcCtD
Nortriptyline—Loss of consciousness—Prednisone—atopic dermatitis	6.95e-05	0.000626	CcSEcCtD
Nortriptyline—Hypotension—Betamethasone—atopic dermatitis	6.93e-05	0.000624	CcSEcCtD
Nortriptyline—Hypotension—Dexamethasone—atopic dermatitis	6.93e-05	0.000624	CcSEcCtD
Nortriptyline—Urticaria—Hydrocortisone—atopic dermatitis	6.89e-05	0.000621	CcSEcCtD
Nortriptyline—Abdominal pain—Hydrocortisone—atopic dermatitis	6.86e-05	0.000618	CcSEcCtD
Nortriptyline—Body temperature increased—Hydrocortisone—atopic dermatitis	6.86e-05	0.000618	CcSEcCtD
Nortriptyline—Convulsion—Prednisone—atopic dermatitis	6.85e-05	0.000617	CcSEcCtD
Nortriptyline—Hypertension—Prednisone—atopic dermatitis	6.83e-05	0.000615	CcSEcCtD
Nortriptyline—Feeling abnormal—Triamcinolone—atopic dermatitis	6.73e-05	0.000606	CcSEcCtD
Nortriptyline—Feeling abnormal—Methylprednisolone—atopic dermatitis	6.72e-05	0.000605	CcSEcCtD
Nortriptyline—Anxiety—Prednisone—atopic dermatitis	6.71e-05	0.000604	CcSEcCtD
Nortriptyline—Insomnia—Dexamethasone—atopic dermatitis	6.7e-05	0.000604	CcSEcCtD
Nortriptyline—Insomnia—Betamethasone—atopic dermatitis	6.7e-05	0.000604	CcSEcCtD
Nortriptyline—Paraesthesia—Dexamethasone—atopic dermatitis	6.66e-05	0.000599	CcSEcCtD
Nortriptyline—Paraesthesia—Betamethasone—atopic dermatitis	6.66e-05	0.000599	CcSEcCtD
Nortriptyline—Discomfort—Prednisone—atopic dermatitis	6.65e-05	0.000599	CcSEcCtD
Nortriptyline—Hypersensitivity—Prednisolone—atopic dermatitis	6.54e-05	0.000589	CcSEcCtD
Nortriptyline—Dyspepsia—Betamethasone—atopic dermatitis	6.52e-05	0.000587	CcSEcCtD
Nortriptyline—Dyspepsia—Dexamethasone—atopic dermatitis	6.52e-05	0.000587	CcSEcCtD
Nortriptyline—Urticaria—Triamcinolone—atopic dermatitis	6.49e-05	0.000584	CcSEcCtD
Nortriptyline—Urticaria—Methylprednisolone—atopic dermatitis	6.47e-05	0.000583	CcSEcCtD
Nortriptyline—Body temperature increased—Triamcinolone—atopic dermatitis	6.46e-05	0.000581	CcSEcCtD
Nortriptyline—Oedema—Prednisone—atopic dermatitis	6.45e-05	0.000581	CcSEcCtD
Nortriptyline—Abdominal pain—Methylprednisolone—atopic dermatitis	6.44e-05	0.00058	CcSEcCtD
Nortriptyline—Decreased appetite—Dexamethasone—atopic dermatitis	6.44e-05	0.00058	CcSEcCtD
Nortriptyline—Decreased appetite—Betamethasone—atopic dermatitis	6.44e-05	0.00058	CcSEcCtD
Nortriptyline—Hypersensitivity—Hydrocortisone—atopic dermatitis	6.39e-05	0.000576	CcSEcCtD
Nortriptyline—Fatigue—Betamethasone—atopic dermatitis	6.39e-05	0.000575	CcSEcCtD
Nortriptyline—Fatigue—Dexamethasone—atopic dermatitis	6.39e-05	0.000575	CcSEcCtD
Nortriptyline—Shock—Prednisone—atopic dermatitis	6.35e-05	0.000572	CcSEcCtD
Nortriptyline—Tachycardia—Prednisone—atopic dermatitis	6.3e-05	0.000567	CcSEcCtD
Nortriptyline—Hyperhidrosis—Prednisone—atopic dermatitis	6.24e-05	0.000562	CcSEcCtD
Nortriptyline—Asthenia—Hydrocortisone—atopic dermatitis	6.22e-05	0.00056	CcSEcCtD
Nortriptyline—Anorexia—Prednisone—atopic dermatitis	6.15e-05	0.000554	CcSEcCtD
Nortriptyline—Pruritus—Hydrocortisone—atopic dermatitis	6.14e-05	0.000553	CcSEcCtD
Nortriptyline—Feeling abnormal—Betamethasone—atopic dermatitis	6.11e-05	0.00055	CcSEcCtD
Nortriptyline—Feeling abnormal—Dexamethasone—atopic dermatitis	6.11e-05	0.00055	CcSEcCtD
Nortriptyline—Hypersensitivity—Triamcinolone—atopic dermatitis	6.02e-05	0.000542	CcSEcCtD
Nortriptyline—Hypersensitivity—Methylprednisolone—atopic dermatitis	6e-05	0.000541	CcSEcCtD
Nortriptyline—Diarrhoea—Hydrocortisone—atopic dermatitis	5.94e-05	0.000534	CcSEcCtD
Nortriptyline—Urticaria—Betamethasone—atopic dermatitis	5.89e-05	0.00053	CcSEcCtD
Nortriptyline—Urticaria—Dexamethasone—atopic dermatitis	5.89e-05	0.00053	CcSEcCtD
Nortriptyline—Dizziness—Prednisolone—atopic dermatitis	5.87e-05	0.000529	CcSEcCtD
Nortriptyline—Asthenia—Triamcinolone—atopic dermatitis	5.86e-05	0.000528	CcSEcCtD
Nortriptyline—Abdominal pain—Betamethasone—atopic dermatitis	5.86e-05	0.000528	CcSEcCtD
Nortriptyline—Body temperature increased—Betamethasone—atopic dermatitis	5.86e-05	0.000528	CcSEcCtD
Nortriptyline—Body temperature increased—Dexamethasone—atopic dermatitis	5.86e-05	0.000528	CcSEcCtD
Nortriptyline—Abdominal pain—Dexamethasone—atopic dermatitis	5.86e-05	0.000528	CcSEcCtD
Nortriptyline—Asthenia—Methylprednisolone—atopic dermatitis	5.85e-05	0.000527	CcSEcCtD
Nortriptyline—Insomnia—Prednisone—atopic dermatitis	5.84e-05	0.000526	CcSEcCtD
Nortriptyline—Paraesthesia—Prednisone—atopic dermatitis	5.8e-05	0.000522	CcSEcCtD
Nortriptyline—Pruritus—Triamcinolone—atopic dermatitis	5.78e-05	0.00052	CcSEcCtD
Nortriptyline—Pruritus—Methylprednisolone—atopic dermatitis	5.77e-05	0.000519	CcSEcCtD
Nortriptyline—Dizziness—Hydrocortisone—atopic dermatitis	5.74e-05	0.000517	CcSEcCtD
Nortriptyline—Dyspepsia—Prednisone—atopic dermatitis	5.68e-05	0.000512	CcSEcCtD
Nortriptyline—Decreased appetite—Prednisone—atopic dermatitis	5.61e-05	0.000505	CcSEcCtD
Nortriptyline—Rash—Prednisolone—atopic dermatitis	5.6e-05	0.000504	CcSEcCtD
Nortriptyline—Dermatitis—Prednisolone—atopic dermatitis	5.6e-05	0.000504	CcSEcCtD
Nortriptyline—Diarrhoea—Methylprednisolone—atopic dermatitis	5.58e-05	0.000502	CcSEcCtD
Nortriptyline—Fatigue—Prednisone—atopic dermatitis	5.56e-05	0.000501	CcSEcCtD
Nortriptyline—Headache—Prednisolone—atopic dermatitis	5.56e-05	0.000501	CcSEcCtD
Nortriptyline—Constipation—Prednisone—atopic dermatitis	5.52e-05	0.000497	CcSEcCtD
Nortriptyline—Vomiting—Hydrocortisone—atopic dermatitis	5.52e-05	0.000497	CcSEcCtD
Nortriptyline—Rash—Hydrocortisone—atopic dermatitis	5.47e-05	0.000493	CcSEcCtD
Nortriptyline—Dermatitis—Hydrocortisone—atopic dermatitis	5.46e-05	0.000492	CcSEcCtD
Nortriptyline—Headache—Hydrocortisone—atopic dermatitis	5.43e-05	0.000489	CcSEcCtD
Nortriptyline—Dizziness—Triamcinolone—atopic dermatitis	5.4e-05	0.000486	CcSEcCtD
Nortriptyline—Dizziness—Methylprednisolone—atopic dermatitis	5.39e-05	0.000485	CcSEcCtD
Nortriptyline—Feeling abnormal—Prednisone—atopic dermatitis	5.32e-05	0.000479	CcSEcCtD
Nortriptyline—Asthenia—Betamethasone—atopic dermatitis	5.32e-05	0.000479	CcSEcCtD
Nortriptyline—Asthenia—Dexamethasone—atopic dermatitis	5.32e-05	0.000479	CcSEcCtD
Nortriptyline—Nausea—Prednisolone—atopic dermatitis	5.28e-05	0.000475	CcSEcCtD
Nortriptyline—Pruritus—Dexamethasone—atopic dermatitis	5.24e-05	0.000472	CcSEcCtD
Nortriptyline—Pruritus—Betamethasone—atopic dermatitis	5.24e-05	0.000472	CcSEcCtD
Nortriptyline—Vomiting—Triamcinolone—atopic dermatitis	5.19e-05	0.000468	CcSEcCtD
Nortriptyline—Vomiting—Methylprednisolone—atopic dermatitis	5.18e-05	0.000467	CcSEcCtD
Nortriptyline—Nausea—Hydrocortisone—atopic dermatitis	5.15e-05	0.000464	CcSEcCtD
Nortriptyline—Rash—Triamcinolone—atopic dermatitis	5.15e-05	0.000464	CcSEcCtD
Nortriptyline—Dermatitis—Triamcinolone—atopic dermatitis	5.15e-05	0.000463	CcSEcCtD
Nortriptyline—Rash—Methylprednisolone—atopic dermatitis	5.14e-05	0.000463	CcSEcCtD
Nortriptyline—Dermatitis—Methylprednisolone—atopic dermatitis	5.13e-05	0.000462	CcSEcCtD
Nortriptyline—Urticaria—Prednisone—atopic dermatitis	5.13e-05	0.000462	CcSEcCtD
Nortriptyline—Headache—Triamcinolone—atopic dermatitis	5.12e-05	0.000461	CcSEcCtD
Nortriptyline—Headache—Methylprednisolone—atopic dermatitis	5.11e-05	0.00046	CcSEcCtD
Nortriptyline—Body temperature increased—Prednisone—atopic dermatitis	5.1e-05	0.000459	CcSEcCtD
Nortriptyline—Abdominal pain—Prednisone—atopic dermatitis	5.1e-05	0.000459	CcSEcCtD
Nortriptyline—Diarrhoea—Betamethasone—atopic dermatitis	5.07e-05	0.000457	CcSEcCtD
Nortriptyline—Diarrhoea—Dexamethasone—atopic dermatitis	5.07e-05	0.000457	CcSEcCtD
Nortriptyline—Dizziness—Betamethasone—atopic dermatitis	4.9e-05	0.000441	CcSEcCtD
Nortriptyline—Dizziness—Dexamethasone—atopic dermatitis	4.9e-05	0.000441	CcSEcCtD
Nortriptyline—Nausea—Triamcinolone—atopic dermatitis	4.85e-05	0.000437	CcSEcCtD
Nortriptyline—Nausea—Methylprednisolone—atopic dermatitis	4.84e-05	0.000436	CcSEcCtD
Nortriptyline—Hypersensitivity—Prednisone—atopic dermatitis	4.76e-05	0.000428	CcSEcCtD
Nortriptyline—Vomiting—Dexamethasone—atopic dermatitis	4.71e-05	0.000424	CcSEcCtD
Nortriptyline—Vomiting—Betamethasone—atopic dermatitis	4.71e-05	0.000424	CcSEcCtD
Nortriptyline—Rash—Dexamethasone—atopic dermatitis	4.67e-05	0.000421	CcSEcCtD
Nortriptyline—Rash—Betamethasone—atopic dermatitis	4.67e-05	0.000421	CcSEcCtD
Nortriptyline—Dermatitis—Dexamethasone—atopic dermatitis	4.67e-05	0.00042	CcSEcCtD
Nortriptyline—Dermatitis—Betamethasone—atopic dermatitis	4.67e-05	0.00042	CcSEcCtD
Nortriptyline—Headache—Betamethasone—atopic dermatitis	4.64e-05	0.000418	CcSEcCtD
Nortriptyline—Headache—Dexamethasone—atopic dermatitis	4.64e-05	0.000418	CcSEcCtD
Nortriptyline—Asthenia—Prednisone—atopic dermatitis	4.63e-05	0.000417	CcSEcCtD
Nortriptyline—Pruritus—Prednisone—atopic dermatitis	4.57e-05	0.000411	CcSEcCtD
Nortriptyline—Diarrhoea—Prednisone—atopic dermatitis	4.42e-05	0.000398	CcSEcCtD
Nortriptyline—Nausea—Dexamethasone—atopic dermatitis	4.4e-05	0.000396	CcSEcCtD
Nortriptyline—Nausea—Betamethasone—atopic dermatitis	4.4e-05	0.000396	CcSEcCtD
Nortriptyline—Dizziness—Prednisone—atopic dermatitis	4.27e-05	0.000384	CcSEcCtD
Nortriptyline—Vomiting—Prednisone—atopic dermatitis	4.1e-05	0.00037	CcSEcCtD
Nortriptyline—Rash—Prednisone—atopic dermatitis	4.07e-05	0.000366	CcSEcCtD
Nortriptyline—Dermatitis—Prednisone—atopic dermatitis	4.07e-05	0.000366	CcSEcCtD
Nortriptyline—Headache—Prednisone—atopic dermatitis	4.04e-05	0.000364	CcSEcCtD
Nortriptyline—Nausea—Prednisone—atopic dermatitis	3.83e-05	0.000345	CcSEcCtD
Nortriptyline—HTR6—GPCR downstream signaling—CXCL8—atopic dermatitis	8.63e-06	0.000253	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CXCR3—atopic dermatitis	8.61e-06	0.000253	CbGpPWpGaD
Nortriptyline—ALB—Transmembrane transport of small molecules—PPARA—atopic dermatitis	8.6e-06	0.000253	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL5—atopic dermatitis	8.57e-06	0.000252	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL5—atopic dermatitis	8.52e-06	0.00025	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CCL5—atopic dermatitis	8.5e-06	0.00025	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	8.42e-06	0.000247	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CXCL10—atopic dermatitis	8.38e-06	0.000246	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ADSL—atopic dermatitis	8.33e-06	0.000245	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	8.29e-06	0.000243	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—CCR5—atopic dermatitis	8.27e-06	0.000243	CbGpPWpGaD
Nortriptyline—HTR6—GPCR downstream signaling—IL2—atopic dermatitis	8.24e-06	0.000242	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	8.24e-06	0.000242	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—CCR5—atopic dermatitis	8.21e-06	0.000241	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL5—atopic dermatitis	8.16e-06	0.00024	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—CXCL8—atopic dermatitis	8.14e-06	0.000239	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	8.14e-06	0.000239	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	8.12e-06	0.000239	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	8.11e-06	0.000238	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TAC1—atopic dermatitis	8.09e-06	0.000238	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NPS—atopic dermatitis	8.09e-06	0.000238	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CCL5—atopic dermatitis	8.01e-06	0.000235	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NPS—atopic dermatitis	7.96e-06	0.000234	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	7.96e-06	0.000234	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NPS—atopic dermatitis	7.94e-06	0.000233	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TAC1—atopic dermatitis	7.94e-06	0.000233	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	7.94e-06	0.000233	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	7.92e-06	0.000233	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NPS—atopic dermatitis	7.92e-06	0.000233	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TAC1—atopic dermatitis	7.89e-06	0.000232	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NPS—atopic dermatitis	7.89e-06	0.000232	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—NGF—atopic dermatitis	7.87e-06	0.000231	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—CXCL8—atopic dermatitis	7.83e-06	0.00023	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NPS—atopic dermatitis	7.82e-06	0.00023	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	7.82e-06	0.00023	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	7.81e-06	0.000229	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	7.8e-06	0.000229	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	7.8e-06	0.000229	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—CXCL8—atopic dermatitis	7.79e-06	0.000229	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CXCR3—atopic dermatitis	7.79e-06	0.000229	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—IL2—atopic dermatitis	7.78e-06	0.000228	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	7.77e-06	0.000228	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CXCR3—atopic dermatitis	7.74e-06	0.000227	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CCL5—atopic dermatitis	7.67e-06	0.000225	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	7.67e-06	0.000225	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CCR5—atopic dermatitis	7.65e-06	0.000225	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	7.65e-06	0.000225	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL5—atopic dermatitis	7.52e-06	0.000221	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—IL2—atopic dermatitis	7.49e-06	0.00022	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—IL2—atopic dermatitis	7.45e-06	0.000219	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—NGF—atopic dermatitis	7.42e-06	0.000218	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	7.41e-06	0.000218	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL5—atopic dermatitis	7.4e-06	0.000217	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—CXCL8—atopic dermatitis	7.39e-06	0.000217	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL5—atopic dermatitis	7.39e-06	0.000217	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL5—atopic dermatitis	7.36e-06	0.000216	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL5—atopic dermatitis	7.34e-06	0.000216	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—CXCL8—atopic dermatitis	7.33e-06	0.000215	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	7.31e-06	0.000215	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	7.27e-06	0.000214	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL5—atopic dermatitis	7.27e-06	0.000214	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	7.25e-06	0.000213	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CCR5—atopic dermatitis	7.22e-06	0.000212	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CCL5—atopic dermatitis	7.22e-06	0.000212	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—NGF—atopic dermatitis	7.11e-06	0.000209	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—CXCL8—atopic dermatitis	7.08e-06	0.000208	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—IL2—atopic dermatitis	7.06e-06	0.000207	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—IL2—atopic dermatitis	7e-06	0.000206	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	6.96e-06	0.000204	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CCR5—atopic dermatitis	6.91e-06	0.000203	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—IL2—atopic dermatitis	6.76e-06	0.000199	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GLB1—atopic dermatitis	6.7e-06	0.000197	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—NGF—atopic dermatitis	6.68e-06	0.000196	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—CXCL8—atopic dermatitis	6.65e-06	0.000195	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CCR5—atopic dermatitis	6.5e-06	0.000191	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—NFKBIA—atopic dermatitis	6.49e-06	0.000191	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ADSL—atopic dermatitis	6.43e-06	0.000189	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	6.41e-06	0.000188	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	6.39e-06	0.000188	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—IL2—atopic dermatitis	6.36e-06	0.000187	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	6.35e-06	0.000187	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.33e-06	0.000186	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	6.31e-06	0.000185	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	6.3e-06	0.000185	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	6.29e-06	0.000185	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	6.28e-06	0.000184	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PPARA—atopic dermatitis	6.27e-06	0.000184	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	6.26e-06	0.000184	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	6.26e-06	0.000184	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	6.2e-06	0.000182	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	6.18e-06	0.000182	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	6.12e-06	0.00018	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	6.1e-06	0.000179	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	6.08e-06	0.000179	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	6.07e-06	0.000178	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—IL2—atopic dermatitis	5.99e-06	0.000176	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	5.99e-06	0.000176	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	5.86e-06	0.000172	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NGF—atopic dermatitis	5.82e-06	0.000171	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	5.81e-06	0.000171	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	5.8e-06	0.00017	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NGF—atopic dermatitis	5.79e-06	0.00017	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	5.77e-06	0.000169	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	5.67e-06	0.000166	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	5.64e-06	0.000166	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	5.61e-06	0.000165	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PPARA—atopic dermatitis	5.56e-06	0.000163	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	5.55e-06	0.000163	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	5.54e-06	0.000163	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	5.52e-06	0.000162	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCL5—atopic dermatitis	5.52e-06	0.000162	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	5.52e-06	0.000162	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	5.51e-06	0.000162	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—NFKBIA—atopic dermatitis	5.51e-06	0.000162	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	5.5e-06	0.000162	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	5.49e-06	0.000161	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	5.47e-06	0.000161	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	5.43e-06	0.00016	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCL5—atopic dermatitis	5.42e-06	0.000159	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	5.42e-06	0.000159	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	5.4e-06	0.000159	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	5.4e-06	0.000159	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	5.4e-06	0.000159	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	5.39e-06	0.000158	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	5.36e-06	0.000157	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	5.33e-06	0.000157	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	5.32e-06	0.000156	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	5.28e-06	0.000155	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	5.27e-06	0.000155	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	5.26e-06	0.000155	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	5.24e-06	0.000154	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	5.23e-06	0.000154	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	5.18e-06	0.000152	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	5.16e-06	0.000152	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NGF—atopic dermatitis	5.11e-06	0.00015	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	5.09e-06	0.00015	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NGF—atopic dermatitis	5.03e-06	0.000148	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NGF—atopic dermatitis	5.02e-06	0.000147	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	5.01e-06	0.000147	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NGF—atopic dermatitis	5e-06	0.000147	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	5e-06	0.000147	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NGF—atopic dermatitis	4.99e-06	0.000147	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	4.98e-06	0.000146	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCR5—atopic dermatitis	4.97e-06	0.000146	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	4.97e-06	0.000146	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NGF—atopic dermatitis	4.94e-06	0.000145	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	4.93e-06	0.000145	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	4.92e-06	0.000144	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	4.9e-06	0.000144	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	4.89e-06	0.000144	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCR5—atopic dermatitis	4.88e-06	0.000143	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	4.87e-06	0.000143	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL2—atopic dermatitis	4.87e-06	0.000143	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	4.85e-06	0.000143	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	4.81e-06	0.000141	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	4.8e-06	0.000141	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	4.79e-06	0.000141	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	4.79e-06	0.000141	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	4.78e-06	0.00014	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL2—atopic dermatitis	4.78e-06	0.00014	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	4.76e-06	0.00014	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	4.75e-06	0.000139	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	4.7e-06	0.000138	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PPARA—atopic dermatitis	4.69e-06	0.000138	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	4.69e-06	0.000138	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PPARA—atopic dermatitis	4.68e-06	0.000137	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CXCL8—atopic dermatitis	4.63e-06	0.000136	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	4.57e-06	0.000134	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL2—atopic dermatitis	4.42e-06	0.00013	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—IL6—atopic dermatitis	4.4e-06	0.000129	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	4.37e-06	0.000128	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	4.22e-06	0.000124	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	4.18e-06	0.000123	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL2—atopic dermatitis	4.17e-06	0.000123	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	4.15e-06	0.000122	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	4.15e-06	0.000122	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	4.14e-06	0.000122	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	4.13e-06	0.000121	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	4.11e-06	0.000121	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	4.07e-06	0.00012	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MAPK8—atopic dermatitis	4.07e-06	0.00012	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	4.06e-06	0.000119	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PPARA—atopic dermatitis	4.03e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL2—atopic dermatitis	3.99e-06	0.000117	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	3.97e-06	0.000117	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CXCL8—atopic dermatitis	3.93e-06	0.000115	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	3.84e-06	0.000113	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL2—atopic dermatitis	3.76e-06	0.00011	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—IL6—atopic dermatitis	3.74e-06	0.00011	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	3.68e-06	0.000108	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PPARA—atopic dermatitis	3.62e-06	0.000106	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MAPK8—atopic dermatitis	3.46e-06	0.000102	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	3.43e-06	0.000101	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	3.41e-06	0.0001	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PPARA—atopic dermatitis	3.33e-06	9.77e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PPARA—atopic dermatitis	3.3e-06	9.69e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL2—atopic dermatitis	3.27e-06	9.62e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	3.26e-06	9.58e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	3.26e-06	9.57e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL2—atopic dermatitis	3.26e-06	9.57e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	3.24e-06	9.52e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	3.12e-06	9.16e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	3.1e-06	9.11e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	3.01e-06	8.85e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	3.01e-06	8.83e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	3e-06	8.81e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	2.96e-06	8.69e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	2.95e-06	8.67e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	2.94e-06	8.65e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	2.93e-06	8.62e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	2.91e-06	8.54e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	2.9e-06	8.51e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL2—atopic dermatitis	2.87e-06	8.44e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	2.87e-06	8.43e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL6—atopic dermatitis	2.86e-06	8.4e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL2—atopic dermatitis	2.83e-06	8.31e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL2—atopic dermatitis	2.82e-06	8.29e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARA—atopic dermatitis	2.82e-06	8.28e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	2.81e-06	8.27e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL2—atopic dermatitis	2.81e-06	8.26e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6—atopic dermatitis	2.81e-06	8.25e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL2—atopic dermatitis	2.8e-06	8.24e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	2.8e-06	8.22e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	2.79e-06	8.2e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL2—atopic dermatitis	2.78e-06	8.16e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	2.77e-06	8.13e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	2.76e-06	8.12e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	2.76e-06	8.09e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	2.65e-06	7.77e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	2.6e-06	7.65e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—atopic dermatitis	2.6e-06	7.64e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	2.6e-06	7.63e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	2.59e-06	7.61e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	2.58e-06	7.58e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	2.56e-06	7.51e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	2.55e-06	7.49e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—atopic dermatitis	2.45e-06	7.2e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—atopic dermatitis	2.35e-06	6.9e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—atopic dermatitis	2.21e-06	6.49e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.18e-06	6.39e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—atopic dermatitis	1.92e-06	5.65e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—atopic dermatitis	1.91e-06	5.62e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	1.83e-06	5.38e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—atopic dermatitis	1.69e-06	4.96e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—atopic dermatitis	1.66e-06	4.88e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—atopic dermatitis	1.66e-06	4.87e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—atopic dermatitis	1.65e-06	4.86e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—atopic dermatitis	1.65e-06	4.84e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—atopic dermatitis	1.63e-06	4.79e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	1.63e-06	4.78e-05	CbGpPWpGaD
